查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1854571

体外二氧化碳清除装置市场按产品类型、接触方式、操作模式、应用和最终用户划分－2025-2032年全球预测

Extracorporeal CO2 Removal Devices Market by Product Types, Access, Mode of Operation, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，体外二氧化碳清除设备市场规模将达到 2.8705 亿美元，复合年增长率为 8.67%。

主要市场统计数据
基准年 2024 1.4755亿美元
预计年份：2025年 1.5968亿美元
预测年份：2032年 2.8705亿美元
复合年增长率 (%) 8.67%

本文简要说明了影响体外二氧化碳清除技术在现代呼吸照护中日益重要作用的临床需求、设备架构和相关人员动态。

体外二氧化碳清除技术正从专门的抢救技术发展成为重症加护、肺科和外科等领域的通用辅助性治疗。临床医生和医院系统越来越将体外二氧化碳清除视为复杂呼吸衰竭的标靶干预措施，尤其是在传统通气策略效果不佳或风险过高的情况下。随着临床途径的不断发展和设备技术的进步，体外二氧化碳清除如何融入更广泛的呼吸治疗方案，以减少人工呼吸器相关性肺损伤、促进保护性通气并作为移植等先进疗法的桥樑，正逐渐清晰地展现在人们的视野中。

本应用报告阐述了目前应用动态的临床原理、核心设备架构和相关人员格局。报告还重点关注设备性能特征、手术入路策略以及与医疗环境的互动，这些因素共同决定了临床疗效和可操作性。奠定这一基础有助于读者更好地理解后续讨论，这些讨论将着重探讨技术曲折点、政策变革、细分市场机会以及区域性考量，这些因素将影响临床医生、医院管理者和设备创新者的近期决策。

技术小型化、自动化和不断发展的临床模式如何重新定义体外二氧化碳清除设备的应用情境、临床管道和采购重点

多项变革性变革正在再形成体外二氧化碳清除技术在临床应用中的构思、设计和部署方式。技术小型化和膜性能的提升使得微创迴路、更低的血流量需求和更短的设定时间成为可能，从而使更多患者群体能够接受治疗，而不仅限于加护病房。同时，自动化和嵌入式控制演算法能够稳定气体交换参数，透过减少对操作者的依赖性来提高安全性，减轻训练负担，并扩大能够安全启动治疗的临床医生范围。

同时，临床实践正转向早期疗育模式，优先考虑肺部保护并避免高强度机械通气。这种临床重点推动了肺科医生、加护治疗监护医生、灌注师和外科团队之间的跨职能合作，并正在製定整合式诊疗路径。供应链的韧性和生产的灵活性正成为医疗器材製造商的策略差异化因素，促使他们投资于模组化设计和在地化生产线。最后，来自註册研究和现场试验的成熟证据，使患者选择、治疗时机以及与传统疗法相比的疗效对比更加清晰，从而支持了通讯协定标准化和医保报销的必要性。

新贸易措施对製造业、采购和临床连续性的累积影响，正在推动整个价值链加速推动在地化、供应商多元化和风险缓解策略。

2025年关税的实施和贸易政策的调整，为依赖全球供应链的体外二氧化碳清除技术製造商、医疗系统和采购机构带来了复杂的考量。关税导致零件成本上涨，促使各方更严格地审查供应商组合，并重新评估筹资策略。许多医疗设备製造商采取的因应措施包括：优化材料清单、加快国内零件供应商的资格认证，以及重新评估生产布局，以降低进口成本波动带来的风险。

医院和综合医疗系统透过重新谈判供应商合约来应对这项挑战，以提高采购弹性，并纳入应对关税和前置作业时间波动的条款。由于一些供应商优先选择产能有限的合约伙伴，临床团队也受到了间接影响，这促使临床工程和供应链团队加强合作，以确保医疗服务的连续性。同时，对本地组装和模具的投资增加，重点关注国产零件的品管和法规合规性。这一转变也导致监管机构对医疗器材的等效性和可追溯性进行更严格的审查，并要求更全面地记录零件来源和上市后监测措施。总体而言，关税主导的市场环境加速了本地化趋势，优先考虑供应商多元化，并凸显了垂直整合对寻求稳定成本基础并为临床客户提供可预测供应的企业的战略价值。

深入分析揭示了产品设计、存取策略、作用机制、临床适应症和最终用户环境如何决定产品的采用管道和价值提案。

透过这种市场细分获得的见解揭示了技术采纳和临床应用的重要细微差别，相关人员差别。根据产品类型，本研究对体外二氧化碳还原（ECCO2R）设备、膜式氧合器和滚压泵的市场进行了分析，重点突出了优先考虑易用性的整合系统与可根据特定临床通讯协定进行定制的模组化组件之间的差异。 ECCO2R 设备在使用者介面、安全联锁和闭合迴路控制方面投入了工程研发，而膜式氧合器和滚压泵则通常专注于改进材料科学和提高耐用性。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 采用新一代膜技​​术的低流量ECCO2R系统的引入降低了溶血和血栓症的风险。
  • 整合人工智慧驱动的监测平台，即时调整体外二氧化碳清除参数，以优化患者疗效。
  • 开发携带式可穿戴二氧化碳清除装置，用于门诊和家庭治疗慢性呼吸衰竭
  • ECCO2R 和连续性肾臟替代联合治疗在重症患者多重器官衰竭的临床检验
  • 医疗器材製造商与製药公司进行策略合作，共同开发辅助性治疗以提高二氧化碳清除率
  • 在二氧化碳清除治疗过程中，实施远端监测和预测分析以提高安全性并缩短住院时间
  • 重点在于开发经济高效的一次性组件和可扩展的生产工艺，以提高ECCO2R系统的经济性和市场可及性。
  • 监管政策的进步和报销政策的更新推动了体外二氧化碳清除技术在加护病房的广泛应用

第六章美国关税的累积影响，2025年

第七章 人工智慧的累积影响，2025年

第八章 体外二氧化碳清除装置市场（依产品类型划分）

  • ECCO2R机器
  • 膜式氧合器
  • 滚筒帮浦

第九章 体外二氧化碳清除装置市场（依接取方式划分）

  • 动脉和静脉
  • 静脉

第十章 体外二氧化碳清除装置市场（依运作模式划分）

  • 自动化系统
  • 手动系统

第十一章 体外二氧化碳清除装置市场：依应用领域划分

  • 急性呼吸窘迫症候群
  • 肺移植桥樑
  • 慢性阻塞性肺病

第十二章 体外二氧化碳清除装置市场（依最终用户划分）

  • 门诊手术中心
  • 居家照护
  • 医院
  • 专科诊所

第十三章 体外二氧化碳清除装置市场：依地区划分

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 体外二氧化碳清除装置市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国体外二氧化碳清除装置市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Aferetica Srl
    • ALung Technologies, Inc. by LivaNova PLC
    • Baxter International Inc.
    • Dragerwerk AG & Co. KGaA
    • Edwards Lifesciences Corporation
    • Estor SpA
    • Fresenius Medical Care AG
    • Getinge AB
    • Inspira-Technologies OXY BHN LTD
    • Koninklijke Philips NV
    • LivaNova PLC
    • Medica SpA
    • MicroPort Scientific Corporation
    • Nikkiso Co., Ltd.
    • NovaLung GmbH
    • Terumo Corporation
    • X-COR Therapeutics
    • XENIOS AG by Fresenius Medical Care AG & Co. KGaA
Product Code: MRR-F927BA462E0F

The Extracorporeal CO2 Removal Devices Market is projected to grow by USD 287.05 million at a CAGR of 8.67% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 147.55 million
Estimated Year [2025] USD 159.68 million
Forecast Year [2032] USD 287.05 million
CAGR (%) 8.67%

A concise orientation to clinical need, device architectures, and stakeholder dynamics shaping the expanding role of extracorporeal CO2 removal in modern respiratory care

Extracorporeal CO2 removal has progressed from a specialized rescue technique to a versatile adjunctive therapy that intersects critical care, pulmonology, and surgical disciplines. Clinicians and hospital systems increasingly view extracorporeal CO2 removal as a targeted intervention for complex respiratory failure scenarios where conventional ventilation strategies are insufficient or carry unacceptable risks. As clinical pathways evolve and device engineering advances, a clearer picture is emerging of how extracorporeal CO2 removal can be integrated into broader respiratory care algorithms to reduce ventilator-induced lung injury, facilitate protective ventilation, and serve as a bridge for advanced therapies such as transplantation.

This introduction frames the clinical rationale, core device architectures, and the stakeholder landscape that together define current adoption dynamics. It highlights the interplay between device performance characteristics, procedural access strategies, and care settings that determine both clinical outcomes and operational feasibility. By establishing this foundation, readers can better appreciate subsequent discussions that focus on technological inflection points, policy disruptions, segmentation-specific opportunities, and regional considerations that will shape near-term decision-making for clinicians, hospital administrators, and device innovators.

How technological miniaturization, automation, and evolving clinical paradigms are jointly redefining device use cases, clinical pathways, and procurement priorities in extracorporeal CO2 removal

Several transformative shifts are reshaping how extracorporeal CO2 removal is conceived, designed, and deployed across clinical settings. Technological miniaturization and improvements in membrane performance are enabling less invasive circuits, lower blood flow requirements, and shorter set-up times, which in turn expand candidate populations beyond intensive care units. Concurrently, automation and embedded control algorithms are enhancing safety by stabilizing gas exchange parameters and reducing operator dependency, thereby lowering training burdens and broadening the pool of clinicians who can safely initiate therapy.

At the same time, clinical practice is shifting toward earlier intervention paradigms that prioritize lung protection and avoidance of high-intensity mechanical ventilation. This clinical emphasis is driving cross-functional collaboration between pulmonologists, intensivists, perfusionists, and surgical teams to develop integrated care pathways. Supply chain resilience and manufacturing agility have become strategic differentiators for device manufacturers, encouraging investment in modular designs and localized production lines. Finally, the maturation of evidence through registries and pragmatic trials is improving clarity on patient selection, timing, and comparative outcomes against conventional care, which collectively supports more standardized protocols and reimbursement conversations.

The cumulative consequences of new trade measures on manufacturing, procurement, and clinical continuity have prompted accelerated localization, supplier diversification, and risk mitigation strategies across the value chain

The imposition of tariffs and trade policy adjustments in 2025 has introduced a complex set of considerations for manufacturers, health systems, and procurement organizations that rely on global supply chains for extracorporeal CO2 removal technologies. Tariff-driven increases in component costs intensified scrutiny of supplier portfolios and incentivized a re-evaluation of sourcing strategies. Many device producers responded by optimizing bill-of-materials, accelerating supplier qualification for domestically sourced components, and reevaluating manufacturing footprints to reduce exposure to import-related cost volatility.

Hospitals and integrated health systems responded by enhancing procurement flexibility and renegotiating vendor contracts to incorporate clauses that address tariff fluctuations and lead time variability. Clinical teams faced indirect effects as some suppliers prioritized contractual partners for constrained production capacity, which necessitated closer collaboration between clinical engineering and supply chain groups to ensure continuity of care. In parallel, investment in local assembly and tooling increased, with an emphasis on quality control and regulatory alignment for domestically produced components. These shifts were accompanied by heightened regulatory scrutiny on device equivalence and traceability, leading to more robust documentation of component provenance and post-market surveillance practices. Collectively, the tariff-driven landscape accelerated localization trends, prioritized supplier diversification, and underscored the strategic value of vertical integration for companies looking to stabilize cost bases and deliver predictable supply to clinical customers.

Segmentation-driven insights reveal how product design, access strategy, operational mode, clinical indication, and end-user environment determine adoption pathways and value propositions

Insights derived from segmentation reveal important nuances in technology adoption and clinical application that stakeholders must consider when formulating strategy. Based on Product Types, market is studied across ECCO2R Machines, Membrane Oxygenators, and Roller pump, and this composition underscores a differentiation between integrated systems that prioritize ease of use and modular components that enable customization for specific clinical protocols. The ECCO2R machines concentrate engineering effort on user interfaces, safety interlocks, and closed-loop control, whereas membrane oxygenators and roller pumps are frequently the focus of incremental materials science and durability improvements.

Based on Access, market is studied across Arteriovenous and Venovenous, and this distinction materially affects procedural risk profiles, vascular access expertise requirements, and the types of clinical teams involved in device deployment. Arteriovenous approaches can offer simplified circuits in certain patient subsets but often require precise vascular assessment; venovenous access tends to be more familiar to critical care teams and integrates more readily with existing extracorporeal expertise. Based on Mode of Operation, market is studied across Automated Systems and Manual Systems, reflecting a bifurcation where automated solutions emphasize closed-loop regulation and reduced operator burden, while manual systems retain flexibility and lower capital intensity for settings with constrained resources. Based on Application, market is studied across Acute Respiratory Distress Syndrome, Bridge to Lung Transplant, and Chronic Obstructive Pulmonary Disease, which points to distinct clinical pathways: ARDS use tends to be acute and protocolized, bridge to transplant requires sustained and reliable support with rigorous infection controls, and COPD applications often emphasize outpatient stabilization and quality-of-life outcomes. Based on End User, market is studied across Ambulatory Surgical Centers, Home Care Settings, Hospitals, and Specialty Clinics, highlighting that deployment models vary from centralized tertiary care to decentralized ambulatory and home-based scenarios, each of which imposes different requirements for device portability, training programs, and post-market support.

Taken together, these segmentation lenses demonstrate that technical specifications, training models, and commercialization strategies cannot be one-size-fits-all. Successful product strategies will align device design with the procedural access profile, operational mode, clinical application, and end-user environment to create clear value propositions that address workflow realities and clinician preferences.

How geographic differences in clinical infrastructure, regulatory pathways, and supply chain resilience shape adoption dynamics and commercial entry strategies for extracorporeal CO2 removal

Regional dynamics create differentiated opportunities and constraints for extracorporeal CO2 removal development and deployment. In the Americas, strong hospital networks, active private equity interest in medical device scale-ups, and established centers of ECMO excellence create fertile ground for early clinical adoption, while reimbursement heterogeneity requires tailored evidence packages to support coverage decisions. Europe, Middle East & Africa presents a diverse regulatory and reimbursement environment where national health systems and regional centers of excellence can serve as strategic entry points, but market access strategies must account for country-level procurement practices and localized clinical guidelines. Asia-Pacific combines rapid hospital capacity expansion with growing domestic manufacturing capability, offering a dual pathway where multinational firms can partner with regional manufacturers to accelerate localization while addressing growing patient volumes in urban centers.

Across these regions, differences in clinician training models, standard-of-care respiratory management, and capital procurement cycles influence how quickly new extracorporeal CO2 removal technologies are adopted. Regional registries and investigator-led studies increasingly drive local guideline development, creating pathways for clinical evidence accumulation that are responsive to regional practice patterns. Furthermore, geographic variations in supply chain resilience and regulatory timelines affect lead times for device introduction and scaling, making region-specific commercial and clinical strategies essential for sustained adoption.

Competitive advantage is emerging for companies that pair engineering differentiation with clinical partnerships, resilient manufacturing, and evidence-driven commercialization strategies

Leading companies in the extracorporeal CO2 removal ecosystem are converging around several strategic imperatives that shape competition and collaboration. First, differentiated engineering investments-such as improved membrane materials, compact pump designs, and integrated monitoring platforms-are central to product roadmaps that aim to expand usability and reduce procedural complexity. Second, partnerships with clinical centers and integrated health systems are being used to generate real-world evidence, refine training protocols, and support early adopter programs that demonstrate clinical and operational value in representative care pathways.

Third, supply chain control and manufacturing agility are distinguishing capabilities; firms that secure multi-sourced critical components and invest in scalable assembly lines reduce exposure to disruptions and trade-policy impacts. Fourth, commercialization strategies increasingly blend direct sales to tertiary centers with distributor models for decentralized settings; this hybrid approach enables rapid penetration while preserving the ability to provide specialized training and service. Finally, companies are investing in post-market data capture and analytics to demonstrate long-term outcomes, inform iterative product improvements, and support reimbursement discussions. Collectively, these trends indicate that competitive advantage will accrue to organizations that combine robust engineering, pragmatic clinical collaboration, flexible commercial models, and resilient manufacturing practices.

Actionable guidance for device manufacturers and healthcare leaders to align product development, evidence generation, supply resilience, and training to accelerate safe adoption

Industry leaders should prioritize a set of actionable strategies to translate technical and clinical advances into durable adoption. First, align product development with clearly defined clinical use cases and procedural workflows, ensuring that device ergonomics, access requirements, and monitoring capabilities map directly to clinician needs and the realities of different care settings. Second, invest in scalable clinical evidence generation through pragmatic registries and multicenter observational studies that address outcomes important to payers, clinicians, and hospital administrators, thereby accelerating reimbursement dialogues and adoption.

Third, diversify sourcing and consider regional assembly hubs to reduce exposure to trade policy shifts and lead-time variability; balance this with robust supplier quality programs to maintain device performance and regulatory compliance. Fourth, build comprehensive training and credentialing programs that combine simulation-based modules with proctored initial procurements to shorten the learning curve and increase clinician confidence. Fifth, explore bundled service offerings that include remote monitoring, consumable management, and responsive field service to reduce total cost of ownership and simplify procurement decisions. Finally, pursue strategic partnerships with pulmonary and critical care opinion leaders to co-develop best-practice protocols that harmonize device use across institutions and support standardized reimbursement claims.

A methodical synthesis of clinical literature, regulatory mapping, expert interviews, and supply chain analysis that triangulates evidence to inform practical decision-making for stakeholders

The research approach combined a structured review of clinical literature, regulatory filings, and publicly available device specifications with targeted expert consultations and supply chain analysis to build a comprehensive understanding of extracorporeal CO2 removal technologies. Clinical evidence was synthesized from peer-reviewed studies, registry reports, and procedural guidelines to delineate use-case definitions, safety profiles, and outcome metrics that clinicians and payers find persuasive. Regulatory pathways were mapped using device approval summaries and guidance documents to identify critical compliance considerations for deployment in different jurisdictions.

Complementing these sources, interviews were conducted with practicing intensivists, perfusionists, hospital procurement leaders, and device engineers to surface operational realities, training challenges, and technology preferences. Supply chain mapping examined component criticality, geographic concentration of suppliers, and manufacturing constraints to assess vulnerability to trade disruptions. Findings were validated through triangulation across independent information streams and by cross-referencing clinical insights with operational data. Limitations include potential lag between newly published clinical results and their incorporation into this analysis and variability in local practice that may influence adoption nuances; where appropriate, assumptions and source timing were documented to support transparent interpretation of the findings.

A concise synthesis of technological progress, clinical adoption drivers, and strategic priorities that frames the practical pathways for durable integration of extracorporeal CO2 removal

In summary, extracorporeal CO2 removal stands at an inflection point where technological progress, evolving clinical approaches, and supply chain dynamics collectively create new opportunities and responsibilities for device makers and healthcare providers. Advances in membrane technology and automation are lowering barriers to use, while diversified access strategies and growing outpatient considerations are expanding the therapy's potential applications. Trade-policy shifts and tariff-related pressures have underscored the importance of supply chain resilience and manufacturing flexibility, prompting a strategic reorientation toward localized sourcing and robust supplier networks.

The path forward requires coordinated action: developers must align engineering priorities with real-world workflows; clinical leaders should collaborate to generate pragmatic evidence that addresses patient-centered outcomes and payer priorities; and procurement teams must incorporate supply continuity and total cost of ownership into purchase decisions. When these elements coalesce, extracorporeal CO2 removal can move from a specialized rescue therapy toward a reliable component of respiratory care strategy that improves patient outcomes while fitting within institutional operational constraints.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of low-flow ECCO2R systems leveraging next-generation membrane technology to reduce hemolysis and thrombosis risk
  • 5.2. Integration of AI-driven monitoring platforms for real-time adjustment of extracorporeal CO2 removal parameters to optimize patient outcomes
  • 5.3. Development of portable and wearable CO2 removal devices for ambulatory care and home-based chronic respiratory failure management
  • 5.4. Clinical validation of combined ECCO2R and continuous renal replacement therapies for multiorgan support in critically ill patients
  • 5.5. Strategic partnerships between device manufacturers and pharmaceutical companies to co-develop adjunctive therapies improving carbon dioxide clearance efficacy
  • 5.6. Implementation of remote telemonitoring and predictive analytics to enhance safety and reduce hospital stay durations in CO2 removal therapy
  • 5.7. Focus on cost-effective disposable components and scalable manufacturing processes to improve affordability and market accessibility of ECCO2R systems
  • 5.8. Regulatory advancements and reimbursement policy updates driving broader adoption of extracorporeal CO2 removal technologies in intensive care units

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Extracorporeal CO2 Removal Devices Market, by Product Types

  • 8.1. ECCO2R Machines
  • 8.2. Membrane Oxygenators
  • 8.3. Roller pump

9. Extracorporeal CO2 Removal Devices Market, by Access

  • 9.1. Arteriovenous
  • 9.2. Venovenous

10. Extracorporeal CO2 Removal Devices Market, by Mode of Operation

  • 10.1. Automated Systems
  • 10.2. Manual Systems

11. Extracorporeal CO2 Removal Devices Market, by Application

  • 11.1. Acute Respiratory Distress Syndrome
  • 11.2. Bridge to Lung Transplant
  • 11.3. Chronic Obstructive Pulmonary Disease

12. Extracorporeal CO2 Removal Devices Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Home Care Settings
  • 12.3. Hospitals
  • 12.4. Specialty Clinics

13. Extracorporeal CO2 Removal Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Extracorporeal CO2 Removal Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Extracorporeal CO2 Removal Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Aferetica Srl
    • 16.3.2. ALung Technologies, Inc. by LivaNova PLC
    • 16.3.3. Baxter International Inc.
    • 16.3.4. Dragerwerk AG & Co. KGaA
    • 16.3.5. Edwards Lifesciences Corporation
    • 16.3.6. Estor S.p.A
    • 16.3.7. Fresenius Medical Care AG
    • 16.3.8. Getinge AB
    • 16.3.9. Inspira-Technologies OXY B.H.N. LTD
    • 16.3.10. Koninklijke Philips N.V.
    • 16.3.11. LivaNova PLC
    • 16.3.12. Medica S.p.A
    • 16.3.13. MicroPort Scientific Corporation
    • 16.3.14. Nikkiso Co., Ltd.
    • 16.3.15. NovaLung GmbH
    • 16.3.16. Terumo Corporation
    • 16.3.17. X-COR Therapeutics
    • 16.3.18. XENIOS AG by Fresenius Medical Care AG & Co. KGaA

LIST OF FIGURES

  • FIGURE 1. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ECCO2R MACHINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ECCO2R MACHINES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ECCO2R MACHINES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ECCO2R MACHINES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ECCO2R MACHINES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ECCO2R MACHINES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE OXYGENATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE OXYGENATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE OXYGENATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE OXYGENATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE OXYGENATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE OXYGENATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ROLLER PUMP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ROLLER PUMP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ROLLER PUMP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ROLLER PUMP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ROLLER PUMP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ROLLER PUMP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ARTERIOVENOUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ARTERIOVENOUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ARTERIOVENOUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ARTERIOVENOUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ARTERIOVENOUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ARTERIOVENOUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY VENOVENOUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY VENOVENOUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY VENOVENOUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY VENOVENOUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY VENOVENOUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY VENOVENOUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY AUTOMATED SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY AUTOMATED SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY AUTOMATED SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY AUTOMATED SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MANUAL SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MANUAL SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MANUAL SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MANUAL SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MANUAL SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MANUAL SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACUTE RESPIRATORY DISTRESS SYNDROME, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACUTE RESPIRATORY DISTRESS SYNDROME, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACUTE RESPIRATORY DISTRESS SYNDROME, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACUTE RESPIRATORY DISTRESS SYNDROME, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACUTE RESPIRATORY DISTRESS SYNDROME, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACUTE RESPIRATORY DISTRESS SYNDROME, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY BRIDGE TO LUNG TRANSPLANT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY BRIDGE TO LUNG TRANSPLANT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY BRIDGE TO LUNG TRANSPLANT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY BRIDGE TO LUNG TRANSPLANT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY BRIDGE TO LUNG TRANSPLANT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY BRIDGE TO LUNG TRANSPLANT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 102. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 103. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2024 (USD MILLION)
  • TABLE 104. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2025-2032 (USD MILLION)
  • TABLE 105. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2024 (USD MILLION)
  • TABLE 106. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2025-2032 (USD MILLION)
  • TABLE 107. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 108. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 109. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 110. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 111. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 112. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2024 (USD MILLION)
  • TABLE 116. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2025-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2024 (USD MILLION)
  • TABLE 118. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2025-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 120. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 122. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 124. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2024 (USD MILLION)
  • TABLE 128. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2025-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2024 (USD MILLION)
  • TABLE 130. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2025-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 132. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 134. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 136. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2024 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2025-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2024 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2025-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 149. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2024 (USD MILLION)
  • TABLE 152. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2025-2032 (USD MILLION)
  • TABLE 153. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2024 (USD MILLION)
  • TABLE 154. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2025-2032 (USD MILLION)
  • TABLE 155. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 156. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 157. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 158. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 159. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 160. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2024 (USD MILLION)
  • TABLE 164. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2025-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2024 (USD MILLION)
  • TABLE 166. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2025-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 168. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 170. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 172. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 173. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2024 (USD MILLION)
  • TABLE 176. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2025-2032 (USD MILLION)
  • TABLE 177. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2024 (USD MILLION)
  • TABLE 178. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2025-2032 (USD MILLION)
  • TABLE 179. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 180. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 181. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 182. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 183. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 184. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2024 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2025-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2024 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2025-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2024 (USD MILLION)
  • TABLE 202. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2025-2032 (USD MILLION)
  • TABLE 203. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2024 (USD MILLION)
  • TABLE 204. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2025-2032 (USD MILLION)
  • TABLE 205. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 206. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 207. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 208. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 209. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 210. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 211. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2024 (USD MILLION)
  • TABLE 214. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2025-2032 (USD MILLION)
  • TABLE 215. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2024 (USD MILLION)
  • TABLE 216. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2025-2032 (USD MILLION)
  • TABLE 217. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 218. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 219. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 220. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 221. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 222. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 235. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2024 (USD MILLION)
  • TABLE 238. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2025-2032 (USD MILLION)
  • TABLE 239. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2024 (USD MILLION)
  • TABLE 240. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2025-2032 (USD MILLION)
  • TABLE 241. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 242. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 243. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 244. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 245. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2024 (USD MILLION)
  • TABLE 250. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2025-2032 (USD MILLION)
  • TABLE 251. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2024 (USD MILLION)
  • TABLE 252. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2025-2032 (USD MILLION)
  • TABLE 253. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 254. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 255. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 256. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 257. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 258. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 259. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2024 (USD MILLION)
  • TABLE 262. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2025-2032 (USD MILLION)
  • TABLE 263. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2024 (USD MILLION)
  • TABLE 264. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2025-2032 (USD MILLION)
  • TABLE 265. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 266. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 267. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 268. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 269. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 270. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2024 (USD MILLION)
  • TABLE 274. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2025-2032 (USD MILLION)
  • TABLE 275. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2024 (USD MILLION)
  • TABLE 276. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2025-2032 (USD MILLION)
  • TABLE 277. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 278. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 279. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 280. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 281. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 282. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 283. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2024 (USD MILLION)
  • TABLE 284. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2025-2032 (USD MILLION)
  • TABLE 285. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2024 (USD MILLION)
  • TABLE 286. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2025-2032 (USD MILLION)
  • TABLE 287. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 288. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 289. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 290. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 291. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 292. CANADA EXTRACORPOREAL CO2 R